When IS3si was given in combination with IM, cell growth was further inhibited in CD34+/CML cells compared with CD34+/Normal cells (p = 0.039; Fig. 5c). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.